# 2025-23545: DEA Rules on Doctor's Fate in Routine Order

2025-23545, David Halvorson, M.D.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-12-22, effective 2026-01-21 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-23545
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-23545
- Title: David Halvorson, M.D.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 59869
- Published: 2025-12-22
- Effective: 2026-01-21
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

DEA Rules on Doctor's Fate in Routine Order

## Summary

Dr. David Halvorson from Alabama lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration as of October 31, 2025. This means he can’t prescribe or manage controlled drugs anymore, effective immediately.

## Effects PRIA read

- DEA Registration Revoked for Dr. Halvorson: cost, high. The DEA revoked David Halvorson, M.D.'s Certificate of Registration No. BH3453278 and denied any pending applications to renew, modify, or obtain additional registration in Alabama. The Order is effective January 21, 2026; the record also shows his Alabama medical license was revoked on or about Ju…
- DEA Policy: State Authority Required: cost, high. Under 21 U.S.C. 824(a)(3) and long-standing DEA precedent cited in this Order, the DEA will revoke a practitioner's federal controlled-substances registration if the practitioner no longer has state authority to dispense controlled substances (for example, after a state license suspension or revoca…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-23545 on federalregister.gov](https://www.federalregister.gov/documents/2025/12/22/2025-23545/david-halvorson-md-decision-and-order)
- [2025-23545 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-12-22/pdf/2025-23545.pdf)

## Related
- [Previous: 2025-23544, Notice of Inventory Completion: Florida Department of State, Tallahassee, FL](https://policyrisk.com/federal-register/2025-23544)
- [Next: 2025-23546, Submission for Office of Management and Budget Review; Proposed Information Col…](https://policyrisk.com/federal-register/2025-23546)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-23545 (as of 2026-06-08).
